SCHEMBL24477015

SCHEMBL24477015

CC(C)c1nc2cccnc2n1-c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.46
ITGB1 P05556 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
ITGA4 P13612 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
POLB P06746 1/20 0.45
PABPC1 P11940 1/20 0.45
AKT1 P31749 4/20 0.44
AKT2 P31751 2/20 0.44
PDE10A Q9Y233 4/20 0.44
CYP1A2 P05177 2/20 0.44
PIK3CD O00329 1/20 0.43
MAPT P10636 1/20 0.43
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 2/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
PDE4A P27815 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11900976 0.88 PDE4B (0.47) PDE4BITGB1CYP3A4CYP2C9ITGA4
SCHEMBL11901109 0.88 PDE4B (0.47) PDE4BITGB1CYP3A4CYP2C9ITGA4
SCHEMBL13506525 0.88 PDE4B (0.47) PDE4BMEN1KMT2APOLBPABPC1
SCHEMBL13053054 0.85 MEN1 (0.47) PDE4BITGB1CYP3A4CYP2C9ITGA4
SCHEMBL4809238 0.83 PDE4B (0.52) PDE4BITGB1CYP3A4CYP2C9ITGA4
SCHEMBL14406434 0.82 MEN1 (0.42) PDE4BITGB1CYP3A4CYP2C9ITGA4
SCHEMBL13733469 0.81 MEN1 (0.46) PDE4BMEN1KMT2APOLBPABPC1
SCHEMBL11901711 0.81 MEN1 (0.46) PDE4BMEN1KMT2APOLBPABPC1
SCHEMBL27930466 0.81 PIK3CD (0.52) PDE4BMEN1KMT2APOLBPABPC1
SCHEMBL540893 0.79 MAPK1 (0.59) PDE4BMEN1KMT2APOLBPABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220173333-A1 HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF CHANGCHUN HYPERIONS TECHNOLOGY CO., LTD (CN) 2022-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220173333-A1 HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE THEREOF KCNH1, OCIAD2, ETFB PDE4B 4145/4885ITGB1 2531/4885CYP3A4 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.